Version: 1.0.0 | Published: 24 Sep 2026 | Updated: 0 days ago
Documentation
Description:
CSF Somascan 7k data measured for 325 participants as part of the complement biomarker study from the European Platform for Neurodegenerative Diseases (EPND). CSF samples were centrally measured at Somalogic. The complement biomarker study is a substudy of the EPND ATN study.
Coverage
Spatial:
US
Follow Up:
Unknown
Provenance
Temporal
Accrual Periodicity:
Static
Start Date:
01 January 2026
Time Lag:
Not applicable
Accessibility
Access
Access Rights:
See dataset for details. Access data at:
Usage
Resource Creators:
Pieter Jelle Visser;,;Marianna Rizzo;,;Stephanie Vos
Observations
Statistical Population
Population Description
Population Size
Measured Property
Observation Date
Persons
325
Count
01 January 2026